Skip to main content
. 2019 Jan;368(1):88–99. doi: 10.1124/jpet.118.252353

Fig. 5.

Fig. 5.

Summary data depicting the effects of MCAM administered intravenously on the percentage choice of remifentanil (panel a) and total choice trials completed (panel b) for each session after the administration of 0.32 (diamonds), 1.0 (triangles), and 3.2 (squares) mg/kg MCAM (n = 3). Data points indicate the mean (±1 S.E.M.) for the group.